Basic results of a study of bilateral adrenalectomy for advanced breast cancer. Urinary steroids and related data in 148 patients
Sarfaty, G.; Pitt, P.; Tallis, M.
Medical Journal of Australia 2(19): 877-881
1973
ISSN/ISBN: 0025-729X PMID: 4128906 Document Number: 62962
Document emailed within 1 workday
Related Documents
Newsome, H.H.; Brown, P.W.; Terz, J.J.; Lawrence, W. 1978: Medical adrenalectomy and plasma steroids in advanced breast carcinoma Surgery 83(1): 83-89Blamey, R. 1980: Transabdominal bilateral adrenalectomy for metastatic breast cancer Annals of the Royal College of Surgeons of England 62(3): 243
Odin, V.I.; Tsyrlina, E.V.; Gamaiunova, V.B.; Bershteĭn, L.M. 1996: Adrenal steroids in patients with breast cancer and in women with age-related impaired glucose tolerance Voprosy Onkologii 42(4): 22-26
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Cosmas, C.; Tsavaris, N.; Malamos, N.; Tsakonas, G.; Gassiamis, A.; Skopelitis, H.; Soukouli, G.; Polyzos, A.; Mylonakis, N.; Karabelis, A. 2005: Dose escalation of docetaxel and ifosfamide in patients with advanced breast cancer failing prior anthracyclines: mature results of a phase I-Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 10(3): 337-346
Moore, F.D.; VanDevanter, S.B.; Boyden, C.M.; Lokich, J.; Wilson, R.E. 1974: Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: objective and subjective response rates; duration and quality of life Surgery 76(3): 376-390
Polák, J. 1985: Prospective study of lung cancer in hospitalized patients. I. Basic data on 618 patients Casopis Lekaru Ceskych 124(31): 977-981
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Bonomi, P.; Gale, M.; Von Roenn, J.; Anderson, K.; Johnson, P.; Wolter, J.; Economou, S. 1988: Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen Seminars in Oncology 15(2 Suppl 1: 26-33
Pérez Lara, F.J.; Navarro Piñero, A.; de la Fuente Perucho, A. 2004: Study of factors related to quality of life in patients with locally advanced rectal cancer Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 96(11): 746-757
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Lebranchu, Y.; Aubert, P.; Bayle, F.; Bedrossian, J.; Berthoux, F.; Bourbigot, B.; Buchler, M.; Chalopin, J.M.; Deteix, P.; Glotz, D.; Huraut De Ligny, B.; Kessler, M.; Lang, P.; Lefrancois, N.; Le Pogamp, P.; Moulin, B.; Mourad, G.; Olmer, M.; Sraer, J.D.; Touchard, G.; Toupance, O.; Wolf, P.; Puget, S. 2000: Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group Transplantation Proceedings 32(2): 396-397
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Taguchi, T.; Mori, S.; Abe, R.; Hasegawa, K.; Morishita, Y.; Tabei, T.; Sasaki, Y.; Fujita, M.; Enomoto, K.; Hamano, K. 1994: Late phase Ii clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(15): 2625-2632
Tominaga, T.; Nomura, Y.; Adachi, I.; Aoyama, H.; Nagao, K.; Mitsuyama, S.; Nakamura, Y.; Ogita, M.; Sano, M.; Takashima, S. 1994: Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 809-816
Nichols, W.C.; Kvols, L.K.; Ingle, J.N.; Edmonson, J.H.; Ahmann, D.L.; Rubin, J.; O'Connell, M.J. 1978: Phase Ii study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy Cancer Treatment Reports 62(5): 837-839
Dorociak, R. 1981: Results of "5-drug" treatment of advanced breast cancer Polski Tygodnik Lekarski 36(38): 1467-1470
Lawson, D.; Moore, M.; Smalley, R. 1980: An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. a pilot study of the Southeastern Cancer Study Group Cancer Clinical Trials 3(4): 293-296
Sparano, J.A. 1998: Compilation of phase i and Ii trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies Seminars in Oncology 25(6 Suppl 13: 10-15
Zieleniewski, J.; Stapor, K. 1972: Remote results of the treatment of Cushing's syndrome with bilateral adrenalectomy and autoimplantation of a part of adrenal cortex Endokrynologia Polska 23(4): 401-405